Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.250
+0.020 (1.63%)
At close: Mar 9, 2026, 4:00 PM EDT
1.230
-0.020 (-1.58%)
After-hours: Mar 9, 2026, 7:58 PM EDT

Immunic Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-97.17-100.51-93.61-120.41-92.95
Upgrade
Depreciation & Amortization
0.170.130.110.080.09
Upgrade
Asset Writedown & Restructuring Costs
-4.8-32.97-
Upgrade
Stock-Based Compensation
8.868.537.17.935.95
Upgrade
Other Operating Activities
0.51.950.524.7612.96
Upgrade
Change in Accounts Payable
1.243.150.820.80.18
Upgrade
Change in Other Net Operating Assets
0.6-2.8214.238.73-9.46
Upgrade
Operating Cash Flow
-85.81-84.77-70.83-65.14-83.23
Upgrade
Capital Expenditures
-0.16-0.26-0.33-0.11-0.07
Upgrade
Investment in Securities
--9.8-9.63-
Upgrade
Investing Cash Flow
-0.16-0.269.46-9.74-0.07
Upgrade
Long-Term Debt Issued
-74.27---
Upgrade
Net Debt Issued (Repaid)
-74.27---
Upgrade
Issuance of Common Stock
65.580.271.0399.7745.84
Upgrade
Other Financing Activities
--0.01--4.01-3
Upgrade
Financing Cash Flow
65.5874.541.0395.7642.84
Upgrade
Foreign Exchange Rate Adjustments
0.21-0.520.26-0.99-0.13
Upgrade
Net Cash Flow
-20.19-11.01-60.0719.88-40.59
Upgrade
Free Cash Flow
-85.97-85.03-71.16-65.26-83.3
Upgrade
Free Cash Flow Per Share
-0.55-0.85-1.61-2.05-3.52
Upgrade
Levered Free Cash Flow
-50.66-53.29-39.98-36.03-49.48
Upgrade
Unlevered Free Cash Flow
-50.66-53.29-39.98-36.03-49.48
Upgrade
Change in Working Capital
1.840.3315.059.53-9.28
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.